Thus, our study offers an effective molecular target for pulmonary fibrosis treatment by identifying the role of HDAC3 in alveolar EMT and fibroblast migration and invasion under hypoxic conditions. The gene discussed is HDAC3; the disease is pulmonary fibrosis.